Novavax (XBUL:NVV1) Total Stockholders Equity : лв-130 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Novavax Total Stockholders Equity?

Novavax's Total Stockholders Equity for the quarter that ended in Mar. 2025 was лв-130 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Novavax's Book Value per Share for the quarter that ended in Mar. 2025 was лв-0.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Novavax's Debt-to-Equity for the quarter that ended in Mar. 2025 was -3.02.

Novavax Total Stockholders Equity Historical Data

The historical data trend for Novavax's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Total Stockholders Equity Chart

Novavax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,080.73

-605.96

-1,092.57

-1,235.32

-1,074.93

Novavax Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															-1,494.06	-743.86	-907.09	-1,074.93	-130.34

Novavax (XBUL:NVV1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Novavax's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-130.339	-	0)	/	161.958
	=	-0.80

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Novavax's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.439	+	384.559)	/	-130.339
	=	-3.02

Novavax Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Novavax's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Novavax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (XBUL:NVV1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany NVAX:Austria

Address

700 Quince Orchard Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Novavax Headlines

No Headlines